Home » Newsletters » BioWorld Science

BioWorld Science

May 31, 2022

View Archived Issues

Novel tricyclic HIV-1 integrase-LEDGF/p75 allosteric inhibitors show improved antiviral activity

Discovery of novel orally bioavailable SERD with enhanced pharmacological properties

NRG Therapeutics receives Biomedical Catalyst award for neurodegenerative disorders

Glycoengineering improves the anti-inflammatory effects of small extracellular vesicles

SLC13A5 inhibitors identified at the Rosalind Franklin University of Medicine and Science

Suzhou Yabao Pharmaceutical Research and Development patents mutant LRRK2 inhibitors

New menin/MLL interaction inhibitors synthesized at Shanghai Euregen Biopharma

Boehringer Ingelheim presents new indoleamine 2,3-dioxygenase 1 inhibitors

New CD73 inhibitors patented by Humanwell Healthcare

PharmEnable and Denali Therapeutics to collaborate in neurodegenerative disease research

RAGE-silencing RNAi suppresses pulmonary allergic inflammation

Cytoplasmic RNA vector expressing anti-CD81 antibodies suppresses experimental arthritis

Studies identify chronic pain mechanisms in skin and spinal cord

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...